Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Kahn Swick & Foti issued a solicitation reminding HIMS investors with losses they have until November 2, 2026 to file lead plaintiff applications in the securities class action Velanki v. Hims & Hers Health, Inc. The class action alleges HIMS failed to disclose material information between August 4, 2025 and July 29, 2026, following an FTC lawsuit accusing the telehealth company of sharing sensitive health data with advertisers and deceptive billing practices.
Key figures
- Class period
- August 4, 2025 to July 29, 2026
- Stock decline
- 14.73%
- Lead plaintiff deadline
- November 2, 2026
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.